Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 173.7 USD 1.15%
Market Cap: 307B USD
Have any thoughts about
Abbvie Inc?
Write Note

EV/EBIT
Enterprise Value to EBIT

23
Current
16
Median
3.6
Industry
Higher than median
Higher than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
23
=
Enterprise Value
354.7B USD
/
EBIT
15.4B USD
All Countries
Close
Market Cap EV/EBIT
US
Abbvie Inc
NYSE:ABBV
303.5B USD 23
FR
Pharnext SCA
OTC:PNEXF
6T USD -216 179.2
US
Amgen Inc
NASDAQ:AMGN
155.8B USD 32.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.1B USD 25.3
US
Gilead Sciences Inc
NASDAQ:GILD
111.8B USD 9.8
US
Epizyme Inc
F:EPE
94.1B EUR -502.9
AU
CSL Ltd
ASX:CSL
132.3B AUD 25.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82B USD 17.9
US
Seagen Inc
F:SGT
39.3B EUR -53.2
NL
argenx SE
XBRU:ARGX
33.8B EUR -74.7
KY
Beigene Ltd
SSE:688235
233.5B CNY -33
EBIT Growth
US
Abbvie Inc
NYSE:ABBV
Average EV/EBIT: 22.3
23
88%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 179.2 N/A
US
Amgen Inc
NASDAQ:AMGN
32.7
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.3
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.8
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -502.9 N/A
AU
CSL Ltd
ASX:CSL
25.1
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.9
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -74.7 N/A
KY
Beigene Ltd
SSE:688235
Negative Multiple: -33 N/A

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
14
2-Years Forward
EV/EBIT
12.5
3-Years Forward
EV/EBIT
11.4

See Also

Discover More